Company registration number 02777449 (England and Wales)
VERDER SCIENTIFIC UK LIMITED
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
PAGES FOR FILING WITH REGISTRAR
VERDER SCIENTIFIC UK LIMITED
CONTENTS
Page
Balance sheet
1
Statement of changes in equity
2
Notes to the financial statements
3 - 9
VERDER SCIENTIFIC UK LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2024
31 December 2024
- 1 -
2024
2023
Notes
£
£
£
£
Fixed assets
Tangible assets
4
40,892
16,278
Current assets
Stocks
367,754
360,595
Debtors
5
924,506
1,008,179
1,292,260
1,368,774
Creditors: amounts falling due within one year
6
(837,008)
(1,094,076)
Net current assets
455,252
274,698
Total assets less current liabilities
496,144
290,976
Provisions for liabilities
(2,364)
(2,506)
Net assets
493,780
288,470
Capital and reserves
Called up share capital
2
2
Profit and loss reserves
493,778
288,468
Total equity
493,780
288,470

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 29 September 2025 and are signed on its behalf by:
Mr T E Gould
Director
Company registration number 02777449 (England and Wales)
VERDER SCIENTIFIC UK LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2024
- 2 -
Share capital
Profit and loss reserves
Total
Notes
£
£
£
Balance at 1 January 2023
2
217,595
217,597
Year ended 31 December 2023:
Profit and total comprehensive income
-
633,254
633,254
Dividends
-
(562,381)
(562,381)
Balance at 31 December 2023
2
288,468
288,470
Year ended 31 December 2024:
Profit and total comprehensive income
-
621,585
621,585
Dividends
-
(416,275)
(416,275)
Balance at 31 December 2024
2
493,778
493,780
VERDER SCIENTIFIC UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
- 3 -
1
Accounting policies
Company information

Verder Scientific UK Limited is a private company limited by shares incorporated in England and Wales. The registered office is Parsons Lane, Hope, Derbyshire, England, S33 6RB.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

This company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements:

 

 

The financial statements of the company are consolidated in the financial statements of Verder International B.V. These consolidated financial statements are available from its registered office, Utrechtseweg 4A, NL 3450 AA Vleuten, Netherlands.

1.2
Going concern

Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Turnover

Revenue comprises sales of goods or services provided to customers net of value added tax and other sales taxes, less an appropriate deduction for actual and expected returns and discounts. Revenue is recognised when performance obligations are satisfied and the control of goods or services is transferred to the buyer. Where the performance obligation is satisfied over time, revenue is recognised in accordance with its progress towards complete satisfaction of that performance obligation.

 

When cash inflows are deferred and represent a financing arrangement, the promised consideration is adjusted for the effects of the time value of money, which is recognised as interest income.

The nature, timing of satisfaction of performance obligations and significant payment terms of the company's major sources of revenue are as follows:

VERDER SCIENTIFIC UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 4 -
Sale of goods

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant and equipment
20% on cost
Motor vehicles
25% on cost

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.5
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.6
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

 

Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

VERDER SCIENTIFIC UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 5 -

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.7
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.8
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.9
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.10
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

VERDER SCIENTIFIC UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 6 -
Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.11
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.12
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.13
Leases
As lessee

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

1.14
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

VERDER SCIENTIFIC UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 7 -
2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

 

The estimates and judgements that have the most material impact on the financial performance and position of the Company are as follows:

 

(i) Valuation of stock

The company is exposed to stock obsolescence caused through changing customer requirements and the risk of over production. Provisions are recorded to reduce the value of stocks to their net realisable value as determined by production forecasts.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2024
2023
Number
Number
Total
7
7
4
Tangible fixed assets
Plant and equipment
Motor vehicles
Total
£
£
£
Cost
At 1 January 2024
47,895
-
0
47,895
Additions
-
0
33,444
33,444
At 31 December 2024
47,895
33,444
81,339
Depreciation and impairment
At 1 January 2024
31,617
-
0
31,617
Depreciation charged in the year
3,256
5,574
8,830
At 31 December 2024
34,873
5,574
40,447
Carrying amount
At 31 December 2024
13,022
27,870
40,892
At 31 December 2023
16,278
-
0
16,278
VERDER SCIENTIFIC UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 8 -
5
Debtors
2024
2023
Amounts falling due within one year:
£
£
Trade debtors
656,879
405,069
Corporation tax recoverable
-
0
37,323
Amounts owed by group undertakings
252,713
554,520
Other debtors
14,914
11,267
924,506
1,008,179

Amounts owed by group undertakings are unsecured, interest free and repayable on demand. Cash pooling balances between the company and Verder International B.V. bear an interest rate of between 0.0% and 6.00% dependant on the currency (2023: 0.0% and 6.00%).

6
Creditors: amounts falling due within one year
2024
2023
£
£
Trade creditors
153,523
258,225
Amounts owed to group undertakings
355,429
629,929
Corporation tax
31,785
-
0
Other taxation and social security
224,723
125,740
Other creditors
71,548
80,182
837,008
1,094,076

Amounts owed to group undertakings are unsecured, interest free and repayable on demand.

7
Audit report information

As the income statement has been omitted from the filing copy of the financial statements, the following information in relation to the audit report on the statutory financial statements is provided in accordance with s444(5B) of the Companies Act 2006.

The auditor's report is unqualified and includes the following:

Opinion

In our opinion the financial statements:

Senior Statutory Auditor:
Paul Newton FCA
Statutory Auditor:
Xeinadin Audit Limited
Date of audit report:
29 September 2025
VERDER SCIENTIFIC UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 9 -
8
Capital commitments

There are no capital commitments as at 31 December 2024 (2023: £Nil).

9
Parent company

The company is wholly owned by Verder Holdings U.K. Ltd, a company incorporated in England and Wales. The ultimate parent company is Verder International B.V., a company incorporated in the Netherlands. The ultimate controlling party is considered to be Mr AJM Verder. All transactions between the company and other group companies were on normal commercial terms and the company has taken advantage of the exemption from disclosing these transactions in its financial statements.

The following are the parents of the largest and smallest groups in which this company's results are consolidated:

Largest group
Verder International B.V.
Smallest group
Verder International B.V.
2024-12-312024-01-01falsefalsefalse29 September 2025CCH SoftwareCCH Accounts Production 2025.200No description of principal activityDr J PankratzMr T E GouldMr R Boulton027774492024-01-012024-12-31027774492024-12-31027774492023-12-3102777449core:PlantMachinery2024-12-3102777449core:MotorVehicles2024-12-3102777449core:PlantMachinery2023-12-3102777449core:MotorVehicles2023-12-3102777449core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3102777449core:CurrentFinancialInstrumentscore:WithinOneYear2023-12-3102777449core:ShareCapital2024-12-3102777449core:ShareCapital2023-12-3102777449core:RetainedEarningsAccumulatedLosses2024-12-3102777449core:RetainedEarningsAccumulatedLosses2023-12-3102777449core:ShareCapital2022-12-3102777449core:RetainedEarningsAccumulatedLosses2022-12-3102777449bus:Director22024-01-012024-12-3102777449core:RetainedEarningsAccumulatedLosses2023-01-012023-12-31027774492023-01-012023-12-3102777449core:RetainedEarningsAccumulatedLosses2024-01-012024-12-3102777449core:PlantMachinery2024-01-012024-12-3102777449core:MotorVehicles2024-01-012024-12-3102777449core:PlantMachinery2023-12-3102777449core:MotorVehicles2023-12-31027774492023-12-3102777449core:CurrentFinancialInstruments2024-12-3102777449core:CurrentFinancialInstruments2023-12-3102777449core:WithinOneYear2024-12-3102777449core:WithinOneYear2023-12-3102777449bus:PrivateLimitedCompanyLtd2024-01-012024-12-3102777449bus:FRS1022024-01-012024-12-3102777449bus:Audited2024-01-012024-12-3102777449bus:Director12024-01-012024-12-3102777449bus:CompanySecretary12024-01-012024-12-3102777449bus:SmallCompaniesRegimeForAccounts2024-01-012024-12-3102777449bus:FullAccounts2024-01-012024-12-31xbrli:purexbrli:sharesiso4217:GBP